Nuclear Basic Fibroblast Growth Factor Regulation of Triple-­Negative Breast Cancer Dormancy/Recurrence

Nuclear Basic Fibroblast Growth Factor Regulation of Triple-­Negative Breast Cancer Dormancy/Recurrence

<p>Chemotherapy remains the only available treatment for triple-negative (TN) breast cancer. Although some TN breast cancers respond initially to neoadjuvant chemotherapy, the majority of patients die within three years of treatment due to recurrent tumor growth. Developing ex vivo models for...

Full description

Bibliographic Details
Main Author: Li, Shenduo
Other Authors: Bachelder, Robin E
Published: 2014
Subjects:
Pathology
breast cancer
cancer biology
DNA-PK
FGF-2
recurrence
triple-negative breast cancer
Online Access:http://hdl.handle.net/10161/9411

Internet

http://hdl.handle.net/10161/9411

Similar Items